Sector consensus Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
00:09:35 19/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2.845 USD | -1.22% |
|
+1.25% | +3.45% |
| 08-19 | BMO Capital Initiates Perspective Therapeutics at Outperform | MT |
| 08-14 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 12.29 | +326.59% | 14 | ||||||
| 688.17 | +26.27% | 23 | ||||||
| 277.94 | +3.16% | 18 | ||||||
| 251.21 | +27.56% | 20 | ||||||
| 432.8 | +22.45% | 28 | ||||||
| 268,686.76 | +49.02% | 22 | ||||||
| 581.83 | -5.42% | 12 | ||||||
| 270.95 | +30.8% | 20 | ||||||
| 72.24 | -6.03% | 14 | ||||||
| 185.25 | +9.18% | 16 | ||||||
| 282.43 | +0.27% | 14 | ||||||
| 68.18 | -15.16% | 17 | ||||||
| 70.73 | -2.32% | 11 | ||||||
| 50.57 | +15.59% | 11 | ||||||
| 137.73 | +16.25% | 22 | ||||||
| 174.69 | +21.57% | 13 | ||||||
| 137.98 | +47.25% | 7 | ||||||
| 3.908 | -17.62% | 7 | ||||||
| 46.27 | +4.25% | 15 | ||||||
| 638.68 | +105.72% | 19 | ||||||
| Average | 13,653.53 | +32.97% | 16 | ||||||
| Weighted average by Cap. | 21,838.14 | +18.56% | 19 |
- Stock Market
- Stocks
- CATX Stock
- Sector Perspective Therapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
